Wednesday's HotCopper trends: Race RC220 doses, West Mits Qala study | July 23
Race Oncology (ASX:RAC) has captured the most attention on the HotCopper forums today after successfully @ and safely @ dosing its first patient with RC220 and RC220 in combination with doxorubicin.Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines ...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
HAZ | Ann: Financing Update | 19/11/16 | 10 | 6.0K | |||
|
|||||||
HAZ | Ann: Company Update | 01/04/16 | 6 | 4.8K | |||
|
|||||||
HAZ | Ann: Appendix 3B - Issue of Convertible Notes | 22/03/16 | 0 | 843 | |||
|
|||||||
HAZ | I need help with HAZ | 16/03/16 | 5 | 3.8K | |||
|
|||||||
HAZ | Ann: Share Consolidation Update | 16/03/16 | 0 | 950 | |||
|
|||||||
HAZ | Ann: Half Year Accounts | 16/03/16 | 0 | 845 | |||
|
|||||||
HAZ | Ann: Results of Meeting | 15/03/16 | 1 | 1.3K | |||
|
|||||||
HAZ | Ann: Becoming a substantial holder | 06/03/16 | 5 | 3.7K | |||
|
See All Discussions